We are hiring! Click to View Open Positions.

Posters

June 2021

Virtual 2021 7th Congress of the European Academy of Neurology (EAN)

Apitegromab, an Investigational Anti-proMyostatin Monoclonal Antibody for Spinal Muscular Atrophy: Phase 2 Results (Presentation)

View This Poster

June 2021

2021 American Society of Clinical Oncology (ASCO) Annual Meeting

First-in-Human Phase 1 Trial (DRAGON) of SRK-181: A Potential First-in-Class Selective Latent TGFβ1 Inhibitor, Alone or in Combination with Anti-PD-(L)1 Treatment in Patients with Advanced Solid Tumors

View This Poster

May 2021

16th International Congress on Neuromuscular Diseases (ICNMD 2021)

TOPAZ: Phase 2 Study Evaluating Efficacy and Safety of Apitegromab in Later-Onset Spinal Muscular Atrophy; An Interim Analysis

View This Poster

April 2021

2021 Virtual American Academy of Neurology (AAN) Annual Meeting

A Phase 2 Study to Evaluate the Efficacy and Safety of Apitegromab (SRK-015) in Patients with Later-Onset Spinal Muscular Atrophy (TOPAZ): Interim Analysis Results

View This Poster

April 2021

American Association for Cancer Research (AACR) Annual Meeting 2021

Development of a Comprehensive Biomarker Strategy to Support the Latent TGFβ1 Inhibitor SRK-181 Phase 1 Clinical Trial, DRAGON

View This Poster

March 2021

2021 MDA Virtual Clinical & Scientific Conference

Apitegromab, a Novel High-Affinity Anti-proMyostatin Monoclonal Antibody for Treating Spinal Muscular Atrophy: Results of a Phase 2 Interim Analysis (Presentation)

View This Poster